O
11.79
0.33 (2.85%)
| Previous Close | 11.46 |
| Open | 11.49 |
| Volume | 319,917 |
| Avg. Volume (3M) | 1,131,441 |
| Market Cap | 682,544,832 |
| Price / Sales | 3.06 |
| Price / Book | 3.27 |
| 52 Weeks Range | |
| Earnings Date | 5 Mar 2026 |
| Profit Margin | -19.83% |
| Operating Margin (TTM) | -15.28% |
| Diluted EPS (TTM) | -0.790 |
| Quarterly Revenue Growth (YOY) | 56.60% |
| Total Debt/Equity (MRQ) | 50.99% |
| Current Ratio (MRQ) | 2.08 |
| Operating Cash Flow (TTM) | -29.65 M |
AIStockmoo Score
1.3
| Analyst Consensus | 1.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 1.5 |
| Technical Oscillators | 2.0 |
| Average | 1.25 |
| % Held by Insiders | 12.14% |
| % Held by Institutions | 45.64% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Cigna Investments Inc /New | 31 Dec 2025 | 3,444,630 |
| Bienville Capital Management, Llc | 31 Dec 2025 | 742,033 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 30.00 (Morgan Stanley, 154.52%) | Buy |
| Median | 20.00 (69.68%) | |
| Low | 17.00 (Wells Fargo, 44.23%) | Hold |
| Average | 22.17 (88.09%) | |
| Total | 5 Buy, 1 Hold | |
| Avg. Price @ Call | 14.61 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| BMO Capital | 06 Mar 2026 | 18.00 (52.71%) | Buy | 14.05 |
| Barclays | 06 Mar 2026 | 18.00 (52.71%) | Buy | 14.05 |
| 03 Mar 2026 | 17.00 (44.23%) | Buy | 13.00 | |
| Canaccord Genuity | 06 Mar 2026 | 22.00 (86.65%) | Buy | 14.05 |
| Morgan Stanley | 06 Mar 2026 | 30.00 (154.52%) | Buy | 14.05 |
| Needham | 22 Jan 2026 | 28.00 (137.56%) | Buy | 16.06 |
| Wells Fargo | 09 Jan 2026 | 17.00 (44.23%) | Hold | 15.41 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 12 Jan 2026 | Announcement | Omada Health Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2025 |
| 08 Jan 2026 | Announcement | Omada Health’s GLP-1 Behavior Change Companion Programs Help Drive Lasting, Long-Term Weight Loss |
| 22 Dec 2025 | Announcement | Omada Health to Participate in J.P. Morgan Healthcare Conference |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |